0001415889-24-010566.txt : 20240409
0001415889-24-010566.hdr.sgml : 20240409
20240409161728
ACCESSION NUMBER: 0001415889-24-010566
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240405
FILED AS OF DATE: 20240409
DATE AS OF CHANGE: 20240409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allison David D.
CENTRAL INDEX KEY: 0001853903
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40353
FILM NUMBER: 24832943
MAIL ADDRESS:
STREET 1: C/O 5AM VENTURES
STREET 2: 501 2ND STREET, SUITE 350
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IPI Legacy Liquidation Co
CENTRAL INDEX KEY: 0001445499
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263058238
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0426
BUSINESS ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
BUSINESS PHONE: 206-568-1466
MAIL ADDRESS:
STREET 1: 201 ELLIOTT AVE. W
STREET 2: SUITE 260
CITY: SEATTLE
STATE: WA
ZIP: 98119
FORMER COMPANY:
FORMER CONFORMED NAME: IMPEL PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20220425
FORMER COMPANY:
FORMER CONFORMED NAME: IMPEL NEUROPHARMA INC
DATE OF NAME CHANGE: 20080917
4
1
form4-04092024_080422.xml
X0508
4
2024-04-05
1
0001445499
IPI Legacy Liquidation Co
IMPLQ
0001853903
Allison David D.
C/O IPI LEGACY LIQUIDATION CO
201 ELLIOTT AVE. W, STE 260
SEATTLE
WA
98119
true
false
false
false
0
Stock Option (right to buy)
9.96
2024-04-05
4
J
0
11500
0
D
2031-07-10
Common Stock
11500
0
D
Stock Option (right to buy)
8.65
2024-04-05
4
J
0
12789
0
D
2032-06-15
Common Stock
12789
0
D
Stock Option (right to buy)
1.34
2024-04-05
4
J
0
13222
0
D
2033-06-15
Common Stock
13222
0
D
Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery.
The option was fully vested.
The option was scheduled to vest in full as of June 16, 2024.
/s/ David D. Allison
2024-04-09